Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-23

FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

The FDA approved a supplemental application for Sumatriptan from Sun Pharmaceutical Industries, Inc., modifying the product's existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)